Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases

Curr Pharm Des. 2018;24(12):1325-1340. doi: 10.2174/1381612824666180417122625.

Abstract

Heterocyclic N-oxides have emerged as promising agents against a number of diseases and disorders, especially infectious diseases. This review analyzes the emergence and development of this scaffold in the medicinal chemistry, focusing mainly on the discovery of new heterocyclic N-oxide compounds with potent activity against tuberculosis, malaria and neglected tropical diseases (i.e. leishmaniasis and Chagas disease). A number of heterocyclic N-oxides are described herein, nevertheless, the following chemical classes deserve to be highlighted due to a large number of reports in the literature about their promising pharmacological effects: furoxan, benzofuroxan, quinoxaline 1,4-di-N-oxide, indolone N-oxide and benzimidazole N-oxide. In order to describe those most promising compounds, we included in this review only those most biologically active heterocyclic Noxide published since 2000.

Keywords: Chagas disease; Heterocyclic N-oxides; N-oxide compounds; drug discovery; leishmaniasis; malaria; neglected tropical diseases; tuberculosis..

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antitubercular Agents / chemistry
  • Antitubercular Agents / therapeutic use*
  • Chagas Disease / drug therapy*
  • Cyclic N-Oxides / chemistry
  • Cyclic N-Oxides / therapeutic use*
  • Humans
  • Leishmaniasis / drug therapy*
  • Malaria / drug therapy*
  • Tuberculosis / drug therapy*

Substances

  • Antitubercular Agents
  • Cyclic N-Oxides